




6% of the patients in European 
hospitals are infected at least 1 HAI
Healthcare-associated infections (HAIs) - statistics
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Healthcare-associated infections (HAIs) - main concerns








• The release and fate of silver nanoparticles into the environment
AgNPs employment - main disadvantages
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• The spray and exaustion at 30ºC was used to continue the work.
Ultrasound Tip
Irregular distribution 
despite its local good 
deposition
Dip Coating
Low amount of AgNPs
and agglomeration
Spray




The best results for 
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pH	effect,	PVP-AgNPs	onto	PES
18



































F	- Exhaustion	30°C w/	AgNPs +	HMDSO









































































































Control	PESW 32.82	± 16.80 104.31	± 8.58
Control	Spray-EtOH 0.53	± 0.84 82,54	± 7.69
Control	Spray-AgNPs 5.70	± 6.15 83.73	± 9.53
Control	Spray-HMDSO 0.41	± 0.87 87.00	± 7.59
Control	Ex.	30°C	- EtOH 95.80	± 9.22 102.47	± 10.60
Control	Ex.	30°C	- HMDSO 99.96	± 9.22 101.42	± 3.71
Spray	HMDSO	+	AgNPs 5.25	± 8.48 98.67	± 7.64
Spray	HMDSO	+	AgNPs +	HMDSO 0.09	± 0.44 97.13	± 2.67
Ex.	30°C	with	AgNPs 83.71	± 4.70 20.96	± 4.60





Control	PESNW 54.89	± 5.87 98.99	± 7.62
Control	Spray-EtOH 20.01	± 5.80 90.70	± 6.24
Control	Spray-AgNPs 62.44	± 3.69 102.61	± 1.91
Control	Spray-HMDSO 84.47	± 2.61 91.66	± 6.18
Control	Ex.	30°C	- EtOH 93.51	± 8.81 88.66	± 4.18
Control	Ex.	30°C	- HMDSO 87.56	± 6.30 83.49	± 7.01
Spray	HMDSO	+	AgNPs 70.32	± 3.51 96.12	± 8.64
Spray	HMDSO	+	AgNPs +	HMDSO 62.62	± 3.94 98.28	± 7.19
Ex.	30°C	with	AgNPs 92.49	± 5.96 1.67	± 1.77
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Thank you for	your attention
